KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System

Stock Information for KORU Medical Systems Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About KORU Medical Systems Inc.

KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference
KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance
KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic
KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin
KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
KORU Medical Systems to Participate in Piper Sandler's 35th Annual Healthcare Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.